Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Small cell lung cancer

A screening strategy based on machine learning for diagnostic biomarkers in small cell lung cancer

Yifeng Pan, Xuansheng Ding, [ ... ], Mingquan Guo

Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis

Zhongqiang Zhang, Zizhe Lin, [ ... ], Shi Xu

Socazolimab combined with carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China

Lian Tang, Yong Chen, [ ... ], PanFeng Feng

A protocol for using human genetic data to identify circulating protein level changes that are the causal consequence of cancer processes

Lisa M. Hobson, Richard M. Martin, [ ... ], Philip C. Haycock

Safety and efficacy of radiotherapy combined with immunotherapy in limited-stage small cell lung cancer a single-arm meta-analysis and systematic review

Li Yu, Xinlin Yu, [ ... ], Ran Cui

Impact of hydatid cyst laminated layer antigens on cell death rate, apoptosis induction, and key genes in the cell proliferation pathway: Insights from A549 cell line studies

ElaheSadat Hosseini, Masoumeh Tavakoli-Yaraki, [ ... ], Raheleh Rafiei-Sefiddashti

Cost-effectiveness analysis of benmelstobart and anlotinib plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: Perspectives from the United States and China

Wenwang Lang, Jiangbo Wang, [ ... ], Lingyue Huang

YOLO-ED: An efficient lung cancer detection model based on improved YOLOv8

Qingqiang Zeng, Tao Hu, [ ... ], Yuanyuan Pan

Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China

Shuo Kang, Shan Zhao, Xiaohui Wang, Zhenhua Pan

Cost-effectiveness analysis of adebrelimab in combination with chemotherapy for first-line treatment of extensive-stage small cell lung cancer

Zhiwei Zheng, Huide Zhu, Ling Fang

Lobectomy versus sublobar resection on survival in patients with stage T1-2N0M0 small cell lung cancer

Xue Yin, Huan-Wei Liang, [ ... ], Xin-Bin Pan

Population interest in and adequacy of the information on the safety of antineoplastic agents in the Spanish edition of Wikipedia

Seira Climent-Ballester, Pedro García-Salom, Javier Sanz-Valero

Tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A cost-effectiveness analysis

Zhiwei Zheng, Huide Zhu, Ling Fang

Advertisement

Create a weekly email alert for: Small cell lung cancer

You can change these options by clicking profile then "Alerts and Notifications"